Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Affiliations

¹ Department of Medicine III, University of Munich, Germany.
² Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
³ Haematology, Peninsula School of Medicine, Plymouth, UK.
⁴ Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'Hématologie & Université Claude Bernard Lyon-1, Pierre-Benite, France.
⁵ Haematology, University-Hospital Città della Salute e della Scienza, Torino.
⁶ Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Free article

Practice Guideline

M Dreyling et al. Ann Oncol. 2016 Sep.

Free article

. 2016 Sep;27(suppl 5):v83-v90.

doi: 10.1093/annonc/mdw400.

¹ Department of Medicine III, University of Munich, Germany.
² Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
³ Haematology, Peninsula School of Medicine, Plymouth, UK.
⁴ Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d'Hématologie & Université Claude Bernard Lyon-1, Pierre-Benite, France.
⁵ Haematology, University-Hospital Città della Salute e della Scienza, Torino.
⁶ Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Erratum in

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M; ESMO Guidelines Committee. Dreyling M, et al. Ann Oncol. 2017 Dec 1;28(12):3109. doi: 10.1093/annonc/mdx020. Ann Oncol. 2017. PMID: 28327933 No abstract available.

No abstract available